Late Breaking Abstract -  Blockade of ß2-adrenoceptor augments anaphylaxis-induced increase in pulmonary vascular permeability in anesthetized mice

T. Shibamoto (Uchinada, Ishikawa, Japan)

Source: International Congress 2017 – Animal models of asthma and allergies
Session: Animal models of asthma and allergies
Session type: Thematic Poster
Number: 1136
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Shibamoto (Uchinada, Ishikawa, Japan). Late Breaking Abstract -  Blockade of ß2-adrenoceptor augments anaphylaxis-induced increase in pulmonary vascular permeability in anesthetized mice. 1136

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018

Late Breaking Abstract - Insulin potentiates methacholine and serotonin-induced increases in tracheal smooth muscle intracellular calcium
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018


Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Late Breaking Abstract - The effects of BMPRII loss on endothelial shear adaptation in the pulmonary vascular endothelium
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


Late Breaking Abstract - Implication of the KATP Sur2b/Kir6.1 in the physiopathology of pulmonary arterial hypertension
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Nitric oxide and beta2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


LSC 2014 abstract - Inhibition of the HIF/leptin/ObR axis prevents experimental pulmonary hypertension and attenuates treg impairment
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014

Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Sustained alveolar hypoxia provokes biphasic vasoconstriction and loss of post-hypoxic vasorelaxation in isolated rabbit lungs
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001

Late Breaking Abstract - Il24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing the m2 program in macrophages
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


The role of anion exchanger on pulmonary vascular response to sustained alveolar hypoxia in the isolated perfused rabbit lung
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008

CRAC channel inhibition by RP3128 ameliorates airway hyper-reactivity in antigen sensitized mice and guinea pigs
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014

Late Breaking Abstract - Effects of preventive exercise in monocrotaline rat model with pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019


Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Anti-contractile and anti-proliferative responses in human pulmonary arterial smooth muscle cells induced by ACT-333679, the active metabolite of selexipag, a non-prostanoid selective prostacyclin receptor agonist
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014